Clinical Trial Update: Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating human mesenchymal stem cells for behavioral problems, including agitation, in Alzheimer's disease; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Agitation in Dementia
• Alzheimer Disease

Drugs mentioned

• Human Mesenchymal Stem Cells (hMSC) (mesenchymal stem cells)

Snippet

Sponsor: Bernard (Barry) Baumel | Conditions: Alzheimer Disease, Agitation in Dementia | Phase 2 | Status: RECRUITING